GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Tailin Bioengineering Co Ltd (SZSE:300813) » Definitions » Equity-to-Asset

Zhejiang Tailin Bioengineering Co (SZSE:300813) Equity-to-Asset : 0.68 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Tailin Bioengineering Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Zhejiang Tailin Bioengineering Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥654.8 Mil. Zhejiang Tailin Bioengineering Co's Total Assets for the quarter that ended in Sep. 2024 was ¥962.1 Mil. Therefore, Zhejiang Tailin Bioengineering Co's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.68.

The historical rank and industry rank for Zhejiang Tailin Bioengineering Co's Equity-to-Asset or its related term are showing as below:

SZSE:300813' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.65   Med: 0.76   Max: 0.9
Current: 0.68

During the past 11 years, the highest Equity to Asset Ratio of Zhejiang Tailin Bioengineering Co was 0.90. The lowest was 0.65. And the median was 0.76.

SZSE:300813's Equity-to-Asset is ranked better than
56.55% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs SZSE:300813: 0.68

Zhejiang Tailin Bioengineering Co Equity-to-Asset Historical Data

The historical data trend for Zhejiang Tailin Bioengineering Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Tailin Bioengineering Co Equity-to-Asset Chart

Zhejiang Tailin Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.82 0.76 0.70 0.67

Zhejiang Tailin Bioengineering Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.67 0.69 0.69 0.68

Competitive Comparison of Zhejiang Tailin Bioengineering Co's Equity-to-Asset

For the Medical Devices subindustry, Zhejiang Tailin Bioengineering Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Tailin Bioengineering Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Tailin Bioengineering Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Zhejiang Tailin Bioengineering Co's Equity-to-Asset falls into.


;
;

Zhejiang Tailin Bioengineering Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Zhejiang Tailin Bioengineering Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=648.763/973.508
=0.67

Zhejiang Tailin Bioengineering Co's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=654.843/962.089
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Tailin Bioengineering Co  (SZSE:300813) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Zhejiang Tailin Bioengineering Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Zhejiang Tailin Bioengineering Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Tailin Bioengineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2930, Nanhuan Road, Binjiang District, Hangzhou, CHN, 310052
Zhejiang Tailin Bioengineering Co Ltd is engaged in designing, manufacturing, and selling the Microbial test and control equipments in China.
Executives
Xia Xin Qun Directors, executives
Ye Xing Yue Secretary Dong
Shen Zhi Lin Directors, executives
Ye Da Lin Directors, executives
Ni Wei Ju Director

Zhejiang Tailin Bioengineering Co Headlines

No Headlines